Back to Results
First PageMeta Content
Organic chemistry / 5-HT3 antagonist / Chemotherapy-induced nausea and vomiting / Ondansetron / Dolasetron / Postoperative nausea and vomiting / Aprepitant / Hyperemesis gravidarum / Chemotherapy / Medicine / Antiemetics / Chemistry


Microsoft Word - NAE Final.doc
Add to Reading List

Document Date: 2014-07-15 14:00:34

Open Document

File Size: 259,72 KB

Share Result on Facebook

Company

Drug Class Review / /

Country

United States / Canada / /

/

Event

FDA Phase / /

Facility

OHSU Center / Oregon State University College of Pharmacy / Science University / /

/

IndustryTerm

pharmaceutical manufacturers / pharmaceuticals / year new pharmaceuticals / /

MedicalCondition

break-through nausea / Post-operative nausea / Radiotherapy-induced nausea / Nausea / diarrhea / constipation / breast cancer / established nausea / abdominal pain / cancer / TBI / chemotherapy-induced nausea / Hyperemesis Gravidarum / infant deformities / vomiting / strabismus / dizziness / moderately emetogenic chemotherapy-induced nausea / dehydration / /

MedicalTreatment

chemotherapy / radiotherapy / surgery / radiation / breast surgery / transplantation conditioning / laparoscopic surgery / total body irradiation / /

MusicGroup

Nausea / /

Organization

Oregon Health and Science University / Food and Drug Administration / Science University Center for Evidence-based Policy / OHSU EPC / EPCs / Standing Update Committee / Office for Oregon Health Policy / Center for Evidence-based Policy / office of Oregon Health Policy & Research / Practice Center / Director Office for Health Policy & Research / Department of Human Services / OHSU Center for Evidence-based Policy / Health Resources Commission / Oregon State University College of Pharmacy / Newer Antiemetic’s Subcommittee / Oregon Legislature / NAE subcommittee / OMAP / Newer Antiemetic Subcommittee / Office for Oregon Health Policy & Research / Health Resources Commission Office for Oregon Health Policy & Research / OHSU Evidence-based Practice Center / /

Person

Kathleen Weaver / /

/

Position

pharmacist / Director / family Nurse / Assistant Director for Health Projects Oregon Health / Post-operative / /

Product

Granisetron / Anzemet / dexamethasone / promethazine / droperidol / Kytril / Zofran / Aloxi / perphenazine / prochlorperazine / metoclopramide / Ondansetron / HT3 / /

ProvinceOrState

Oregon / /

PublishedMedium

Journal of Clinical Oncology / /

RadioStation

2 What / /

Technology

radiation / transplantation / chemotherapy / /

URL

www.oregon.gov/DAS/OHPPR/ORRX/HRC/evidence_based_reports.shtml / http /

SocialTag